SMAIO news, videos and press releases
For more news please use our advanced search feature.
SMAIO - More news...
SMAIO - More news...
- SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States
- SMAIO Provides Update on Its Partnership With NuVasive and Confirms Its Strategic Focus on the U.S. Market
- SMAIO Announces 2024 Sales of €5.5m, More Than Half of Which Generated in the United States
- SMAIO: 2025 Financial Calendar
- SMAIO Publishes its 2023 Annual Results
- SMAIO: First-Half 2023 Sales up +203% to €4.0 Million
- SMAIO Obtains €2.5m in Non-dilutive Financing
- SMAIO Receives FDA 510(k) Clearance for Customized Surgery Planning Software Co-Developed with NuVasive
- SMAIO Reports Its 2022 Annual Results and Confirms Its 2023 Outlook
- SMAIO: 2022 Annual Sales up +15% to €2.4 Million
- SMAIO: 2023 Financial Calendar
- SMAIO: Success of the First Educational Program in the United States, the World’s Largest Spine Market
- SMAIO Announces the Success of Its First European Educational Programs
- SMAIO Announces Its First-half 2022 Results
- SMAIO: First-half 2022 Sales up +28% to €1.3 Million
- SMAIO Receives FDA 510(k) Clearance for “K-rod”, its Patient-specific Union Rod
- TP ICAP Midcap Initiates Coverage of SMAIO With a “Buy” Recommendation
- SMAIO Receives FDA 510(k) Clearance for Its Balance Analyzer 3D Surgery Planning Software
- SMAIO, Pioneer of a Holistic Approach to Spinal Surgery, Announces Its 2021 Annual Results and Confirms Its 2022 Outlook
